Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Randomized Controlled Trials Drug Approval Cancer Research Efficacy Studies

5 ARTICLES

yesterday

HHS and ARPA-H Launch SURPASS to Rebuild U.S. Clinical Trials

The program seeks to slash drug development time and cost by testing phaseless trials, real‑time analytics and automation while using federal data and regulator coordination to create reusable trial blueprints.

5 ARTICLES

yesterday

Sanofi Expands Regeneron Collaboration With $1 Billion Upfront for Four Antibody Programs

40 ARTICLES

yesterday

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

4 ARTICLES

2d ago

ASTRO 2026 to Spotlight Phase 3 Trial Results and Mayo Clinic First‑in‑Human Minibeam Data

20 ARTICLES

last wk.

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

4 ARTICLES

last wk.

Wide Plasma Proteomics Study Finds Distinct Blood Signals for Amyloid Clearance and Cognitive Change in Patients on Lecanemab

7 ARTICLES

last wk.

FDA Approves Lilly’s Once-Weekly Basal Insulin Onswik for Adults With Type 2 Diabetes

5 ARTICLES

last wk.

NHS Launches Pilot to Cut Brain Tumour Diagnosis from Weeks to Hours

3 ARTICLES

last wk.

Acadia’s Alzheimer’s Psychosis Drug Misses Mid‑Stage Goal

3 ARTICLES

last wk.

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

8 ARTICLES

last wk.

FDA Advisory Panel Reviews GRAIL’s Galleri Multi‑Cancer Blood Test

5 ARTICLES

last wk.

Viking’s VK2735 Shows Durable Weight Loss With Less‑Frequent Dosing

3 ARTICLES

last wk.

Amgen’s Dazodalibep Meets Primary Goal in Phase 3 Sjögren’s Trial

11 ARTICLES

last wk.

Alzheimer’s Research Enters a New Era as Trials Multiply and Diagnosis Scales Up

4 ARTICLES

last wk.

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

5 ARTICLES

last wk.

DR Congo Begins Ervebo Vaccinations for Frontline Ebola Workers

Clinical Trials

HHS and ARPA-H Launch SURPASS to Rebuild U.S. Clinical Trials

Sanofi Expands Regeneron Collaboration With $1 Billion Upfront for Four Antibody Programs

Retatrutide Drives Record Weight Loss in Type 2 Diabetes, Company Moves Toward U.S. Filing

Orforglipron Found Noninferior to Insulin Glargine for Major Heart Events

Phase 3 Trials at ASTRO Strengthen Case for Focused, Short‑Course Radiation

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

FDA Approves Juvmo as First D1/D5 Agonist for Parkinson’s Disease

ASTRO 2026 to Spotlight Phase 3 Trial Results and Mayo Clinic First‑in‑Human Minibeam Data

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

Wide Plasma Proteomics Study Finds Distinct Blood Signals for Amyloid Clearance and Cognitive Change in Patients on Lecanemab

Never miss stories about

Clinical Trials

FDA Approves Lilly’s Once-Weekly Basal Insulin Onswik for Adults With Type 2 Diabetes

NHS Launches Pilot to Cut Brain Tumour Diagnosis from Weeks to Hours

Acadia’s Alzheimer’s Psychosis Drug Misses Mid‑Stage Goal

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

FDA Advisory Panel Reviews GRAIL’s Galleri Multi‑Cancer Blood Test

Viking’s VK2735 Shows Durable Weight Loss With Less‑Frequent Dosing

Amgen’s Dazodalibep Meets Primary Goal in Phase 3 Sjögren’s Trial

Alzheimer’s Research Enters a New Era as Trials Multiply and Diagnosis Scales Up

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

DR Congo Begins Ervebo Vaccinations for Frontline Ebola Workers

Never miss stories about

Clinical Trials